Total Payments
$8,938
2024 Payments
$1,192
Companies
30
Transactions
409
Medicare Patients
12,778
Medicare Billing
$848,225
Payment Breakdown by Category
Food & Beverage$7,254 (81.2%)
Consulting$1,138 (12.7%)
Education$546.52 (6.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,254 | 400 | 81.2% |
| Consulting Fee | $1,138 | 1 | 12.7% |
| Education | $546.52 | 8 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,112 | 176 | $0 (2024) |
| GENZYME CORPORATION | $706.25 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $580.69 | 18 | $0 (2023) |
| LEO Pharma Inc. | $557.56 | 36 | $0 (2024) |
| PFIZER INC. | $465.06 | 45 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $269.16 | 18 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $269.03 | 5 | $0 (2023) |
| Incyte Corporation | $268.79 | 15 | $0 (2024) |
| Amgen Inc. | $247.18 | 10 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $225.00 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,192 | 67 | ABBVIE INC. ($592.20) |
| 2023 | $1,387 | 85 | ABBVIE INC. ($570.70) |
| 2022 | $1,479 | 90 | ABBVIE INC. ($621.19) |
| 2021 | $922.44 | 56 | AbbVie Inc. ($430.65) |
| 2020 | $1,549 | 17 | AbbVie Inc. ($1,256) |
| 2019 | $777.14 | 35 | AbbVie, Inc. ($249.70) |
| 2018 | $929.64 | 41 | AbbVie, Inc. ($391.47) |
| 2017 | $701.83 | 18 | GENZYME CORPORATION ($152.75) |
All Payment Transactions
409 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.52 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Immunology | ||||||
| 09/23/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: DERMATOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.14 | General |
| Category: Immunology | ||||||
| 08/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,108 | 6,593 | $694,148 | $206,454 |
| 2022 | 25 | 3,356 | 7,265 | $755,968 | $221,725 |
| 2021 | 26 | 3,127 | 6,744 | $743,313 | $226,566 |
| 2020 | 26 | 3,187 | 6,479 | $725,165 | $193,480 |
Total Patients
12,778
Total Services
27,081
Medicare Billing
$848,225
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 596 | 779 | $155,800 | $44,722 | 28.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 620 | 892 | $129,340 | $32,444 | 25.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 255 | 295 | $69,325 | $21,097 | 30.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 398 | 460 | $57,500 | $15,751 | 27.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 519 | 3,268 | $65,360 | $14,988 | 22.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 88 | 123 | $36,900 | $14,453 | 39.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 204 | 242 | $46,222 | $14,224 | 30.8% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 15 | 38 | $18,050 | $11,501 | 63.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 53 | 60 | $21,540 | $7,287 | 33.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 41 | 46 | $14,030 | $4,287 | 30.6% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 17 | 34 | $8,500 | $3,256 | 38.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 14 | 15 | $8,880 | $3,102 | 34.9% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 22 | 23 | $9,085 | $3,080 | 33.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $8,325 | $2,460 | 29.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 39 | 67 | $7,437 | $2,297 | 30.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 24 | 24 | $6,000 | $2,190 | 36.5% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 16 | 17 | $5,984 | $1,944 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 20 | $5,500 | $1,784 | 32.4% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 22 | 22 | $4,620 | $1,670 | 36.1% |
| 69100 | Biopsy of ear | Office | 2023 | 20 | 24 | $5,040 | $1,318 | 26.2% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 13 | $3,120 | $931.53 | 29.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 20 | 20 | $3,500 | $825.64 | 23.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 16 | 20 | $2,220 | $605.90 | 27.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 14 | $770.00 | $117.60 | 15.3% |
| Q0112 | All potassium hydroxide (koh) preparations | Office | 2023 | 15 | 18 | $990.00 | $102.79 | 10.4% |
About Dr. Richard Murphy, MD
Dr. Richard Murphy, MD is a Dermatology healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861414286.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Murphy, MD has received a total of $8,938 in payments from pharmaceutical and medical device companies, with $1,192 received in 2024. These payments were reported across 409 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($7,254).
As a Medicare-enrolled provider, Murphy has provided services to 12,778 Medicare beneficiaries, totaling 27,081 services with total Medicare billing of $848,225. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Greenville, NC
- Active Since 07/24/2006
- Last Updated 11/06/2015
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1861414286
Products in Payments
- HUMIRA (Biological) $1,422
- SKYRIZI (Biological) $1,372
- RINVOQ (Biological) $636.25
- ADBRY (Biological) $530.10
- DUPIXENT (Biological) $502.50
- EUCRISA (Drug) $465.06
- TREMFYA (Drug) $450.82
- Otezla (Drug) $406.74
- Humira (Biological) $281.96
- OPZELURA (Drug) $268.79
- Tremfya (Drug) $254.88
- COSENTYX (Biological) $241.84
- DUPIXENT (Drug) $205.25
- SPEVIGO (Drug) $133.97
- DUPIXENT DUPILUMAB INJECTION (Biological) $125.00
- ATOPIC DERMATITIS - DISEASE (Drug) $115.15
- Sotyktu (Drug) $113.82
- Xolair (Biological) $113.00
- Skyrizi (Biological) $108.19
- STELARA (Biological) $99.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Greenville
Dr. Marshall Shuler, M.d, M.D
Dermatology — Payments: $2.5M
Dermatology $2.5M
Dr. Joseph Terracina, M.d. P.a, M.D. P.A
Dermatology — Payments: $77,590
Dermatology $77,590
Matthew Miller, Md, MD
Dermatology — Payments: $29,031
Dermatology $29,031
Leslie Poinsette, Md, MD
Dermatology — Payments: $16,726
Dermatology $16,726
Dr. Eric Howell
Dermatology — Payments: $14,791
Dermatology $14,791
Ms. Caroline Price, Md, MD
Dermatology — Payments: $11,987
Dermatology $11,987